Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
687.00    -5.00 (-0.72%)
Bid:
680.00
Ask:
694.00
Spread: 14.00 (2.059%)
Market Cap: £242.09m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Investment

22 Sep 2025 15:23

RNS Number : 3004A
B.P. Marsh & Partners PLC
22 September 2025
 

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to announce that it has acquired a 35% Cumulative Preferred Ordinary shareholding in Salus, a start-up UK-based insurance intermediary group, specialising in Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of equity and a loan facility. The loan facility was partially drawn down upon completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte") and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting UK-domiciled businesses including Architects, Engineers, Construction, Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity insurance for small to medium-sized businesses, with an initial focus on Construction, Surveyors and Accountancy. Salus has been founded by four experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow and Stuart Barker whose collective experience in insurance broking and underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a premier, client-focused brokerage and underwriting agency, headquartered in Bristol, providing its clients with access to the speciality Broking and Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their business plan of building a successful Professional Indemnity brokerage and underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team brings a significant amount of insurance experience, expertise, and relationships. We look forward to working with B.P. Marsh over the years to come to achieve our goals."

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

David Watkins / Atholl Tweedie / Amrit Mahbubani

 

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSALIFFIE
Date   Source Headline
2nd Nov 20173:17 pmRNSDirector/PDMR Shareholding
31st Oct 201712:04 pmRNSDirector/PDMR Shareholding
26th Oct 20174:00 pmRNSInvestee Company Update
24th Oct 20177:02 amRNSDirector/PDMR Shareholding
24th Oct 20177:01 amRNSDirector/PDMR Shareholding
24th Oct 20177:00 amRNSDirector/PDMR Shareholding
19th Oct 20173:55 pmRNSDirector/PDMR Shareholding
17th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSInvestment in Mark Edward Partners LLC
7th Sep 20177:00 amRNSTrading Update
6th Sep 20177:00 amRNSDirectorate Change
31st Jul 20176:06 pmRNSDirector/PDMR Shareholding
31st Jul 20176:04 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSInvestee Company Update
24th Jul 20173:50 pmRNSShare Buy-Back Policy
19th Jul 20174:24 pmRNSResult of AGM
19th Jul 20179:16 amRNSInvestee Company Update
18th Jul 20172:07 pmRNSInvestee Company Update - Nexus Underwriting
13th Jul 20175:10 pmRNSInvestee Company Update
5th Jul 20173:25 pmRNSDirector/PDMR Shareholding
30th Jun 201710:36 amRNSInvestee Company Update - Nexus Underwriting
29th Jun 20173:26 pmRNSShare Incentive Plan
28th Jun 20173:07 pmRNSNotice of AGM
19th Jun 20173:20 pmRNSInvestment
14th Jun 20173:55 pmRNSDirector/PDMR Shareholding
14th Jun 20172:56 pmRNSDirector/PDMR Shareholding
13th Jun 20171:10 pmRNSInvestment in North America
12th Jun 20174:01 pmRNSDirector/PDMR Shareholding
12th Jun 20173:56 pmRNSDirector/PDMR Shareholding
9th Jun 20177:05 amRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20177:00 amRNSFinal Results
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
24th Apr 20174:40 pmRNSChange of Registered Office
19th Apr 20175:40 pmRNSResult of General Meeting
12th Apr 20174:07 pmRNSBesso Disposal Update
6th Apr 20175:36 pmRNSDirector/PDMR Shareholding
5th Apr 201712:28 pmRNSPDMR Share Sale Plan
3rd Apr 201712:43 pmRNSDisposal and Notice of General Meeting
16th Mar 20174:50 pmRNSTransaction in Own Shares
15th Mar 20175:04 pmRNSShare Buy-Back Policy Update
15th Mar 20175:02 pmRNSDirector/PDMR Shareholding
15th Mar 20172:47 pmRNSTransaction in Own Shares
14th Mar 20172:16 pmRNSTransaction in Own Shares
13th Mar 20173:56 pmRNSTransaction in Own Shares
10th Mar 20176:18 pmRNSTransaction in Own Shares
3rd Mar 20173:23 pmRNSTransaction in Own Shares
3rd Mar 20173:21 pmRNSDirector/PDMR Shareholding
3rd Mar 201711:12 amRNSShare Buy-Back Policy
28th Feb 20174:17 pmRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.